| Primary |
| Product Used For Unknown Indication |
25.5% |
| Angina Pectoris |
23.3% |
| Hypertension |
11.6% |
| Coronary Artery Disease |
7.3% |
| Type 2 Diabetes Mellitus |
5.1% |
| Diabetes Mellitus |
4.0% |
| Ischaemic Cardiomyopathy |
3.7% |
| Cardiac Failure |
2.4% |
| Constipation |
2.0% |
| Hypercholesterolaemia |
1.8% |
| Myocardial Infarction |
1.8% |
| Atrial Fibrillation |
1.7% |
| Hyperlipidaemia |
1.7% |
| Pain |
1.7% |
| Myocardial Ischaemia |
1.3% |
| Anticoagulant Therapy |
1.1% |
| Blood Pressure |
1.1% |
| Hyperthyroidism |
1.1% |
| Anaemia |
0.9% |
| Antiplatelet Therapy |
0.9% |
|
| Death |
20.8% |
| Syncope |
11.5% |
| Vomiting |
10.4% |
| Dizziness |
7.3% |
| Renal Failure Acute |
6.3% |
| Asthenia |
5.2% |
| Tremor |
5.2% |
| Rhabdomyolysis |
4.2% |
| Confusional State |
3.1% |
| Hepatic Enzyme Increased |
3.1% |
| Nausea |
3.1% |
| Torsade De Pointes |
3.1% |
| Anger |
2.1% |
| Blood Creatinine Increased |
2.1% |
| Blood Glucose Abnormal |
2.1% |
| Bradycardia |
2.1% |
| Cardiac Failure Congestive |
2.1% |
| Cough |
2.1% |
| Fall |
2.1% |
| Headache |
2.1% |
|
| Secondary |
| Product Used For Unknown Indication |
42.7% |
| Angina Pectoris |
14.1% |
| Drug Use For Unknown Indication |
11.2% |
| Hypercholesterolaemia |
5.4% |
| Hypertension |
4.9% |
| Coronary Artery Disease |
4.7% |
| Cardiac Failure |
2.8% |
| Urinary Tract Infection |
2.6% |
| Type 2 Diabetes Mellitus |
1.9% |
| Myocardial Ischaemia |
1.5% |
| Hyperlipidaemia |
1.3% |
| Myocardial Infarction |
1.2% |
| Renal Transplant |
1.1% |
| Diabetes Mellitus |
0.8% |
| Osteoporosis |
0.8% |
| Parkinson's Disease |
0.7% |
| Atrial Fibrillation |
0.6% |
| Chest Pain |
0.6% |
| Arrhythmia Prophylaxis |
0.5% |
| Nephropathy |
0.5% |
|
| Rhabdomyolysis |
17.2% |
| Completed Suicide |
10.3% |
| Arthralgia |
9.5% |
| Vomiting |
9.5% |
| Musculoskeletal Pain |
7.8% |
| Drug Interaction |
6.9% |
| Malaise |
5.2% |
| Renal Failure Acute |
4.3% |
| Renal Impairment |
4.3% |
| Asthenia |
3.4% |
| Dizziness |
2.6% |
| Pancreatitis |
2.6% |
| Retinal Detachment |
2.6% |
| Transient Ischaemic Attack |
2.6% |
| Vision Blurred |
2.6% |
| Blood Creatine Phosphokinase Increased |
1.7% |
| Blood Glucose Abnormal |
1.7% |
| Cardiac Failure Congestive |
1.7% |
| Chromaturia |
1.7% |
| Fatigue |
1.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
38.7% |
| Drug Use For Unknown Indication |
19.9% |
| Angina Pectoris |
16.4% |
| Type 2 Diabetes Mellitus |
4.0% |
| Hypertension |
2.9% |
| Prophylaxis |
2.1% |
| Coronary Artery Disease |
1.5% |
| Hypercholesterolaemia |
1.4% |
| Cardiac Disorder |
1.3% |
| Myocardial Infarction |
1.3% |
| Rheumatoid Arthritis |
1.3% |
| Atrial Fibrillation |
1.2% |
| Chest Discomfort |
1.2% |
| Anxiety |
1.1% |
| Blood Cholesterol |
1.1% |
| Pain |
1.1% |
| Blood Cholesterol Increased |
1.0% |
| Acute Myocardial Infarction |
0.9% |
| Chest Pain |
0.9% |
| Diabetes Mellitus |
0.9% |
|
| Musculoskeletal Chest Pain |
14.6% |
| Angina Pectoris |
12.2% |
| Syncope |
7.3% |
| Death |
6.1% |
| Myocardial Infarction |
6.1% |
| Dyspnoea |
4.9% |
| Flushing |
4.9% |
| Hypersensitivity |
4.9% |
| Serratia Infection |
4.9% |
| Hypotension |
3.7% |
| Pain |
3.7% |
| Pancreatitis Acute |
3.7% |
| Rhabdomyolysis |
3.7% |
| Urinary Retention |
3.7% |
| Vitreous Disorder |
3.7% |
| Acute Coronary Syndrome |
2.4% |
| Arterial Occlusive Disease |
2.4% |
| Brain Natriuretic Peptide Increased |
2.4% |
| Chest Pain |
2.4% |
| Completed Suicide |
2.4% |
|
| Interacting |
| Product Used For Unknown Indication |
51.4% |
| Angina Pectoris |
14.4% |
| Chest Pain |
6.2% |
| Hypercholesterolaemia |
6.2% |
| Atrial Fibrillation |
4.1% |
| Myocardial Ischaemia |
4.1% |
| Abnormal Behaviour |
2.7% |
| Hyperlipidaemia |
2.1% |
| Behavioural And Psychiatric Symptoms Of Dementia |
1.4% |
| Cognitive Disorder |
1.4% |
| Hypertriglyceridaemia |
1.4% |
| Renal Transplant |
1.4% |
| Urinary Tract Infection |
1.4% |
| Diuretic Therapy |
0.7% |
| Diverticulitis |
0.7% |
| Prophylaxis |
0.7% |
|
| Rhabdomyolysis |
32.4% |
| International Normalised Ratio Increased |
16.2% |
| Immunosuppressant Drug Level Increased |
10.8% |
| Vomiting |
8.1% |
| Blood Creatine Phosphokinase Increased |
5.4% |
| Renal Failure Acute |
5.4% |
| Urinary Retention |
5.4% |
| Drug Interaction |
2.7% |
| Dyspnoea |
2.7% |
| Electrocardiogram Qt Prolonged |
2.7% |
| Myopathy |
2.7% |
| Pain In Extremity |
2.7% |
| Tremor |
2.7% |
|
